Your search relates to more than one category
Philadelphia Inquirer (Free subscription) | 11/12/2009
SWIFTWATER, Pa. - Sanofi-Aventis Group, under pressure with other vaccine-makers to meet intense public demand for flu vaccine in the United States, yesterday said it solved problems that had slowed production and was working around-the-clock to deliver the 75 million doses of H1N1 vaccine it promised the federal government by the end of December.
Business Wire (Free subscription) | 10/26/2009
SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced that its board of directors elected David J. Williams, former chairman and CEO of Sanofi Pasteur, the vaccine business of Sanofi-Aventis Group, and Keith H. Wells, a senior member of the Biologics Consulting Group and former director of...
The Earth Times Online Newspaper (Free subscription) | 10/26/2009
SAN DIEGO - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced that its board of directors elected David J. Williams, former chairman and CEO of Sanofi Pasteur, the vaccine business of Sanofi-Aventis Group, and Keith H. Wells,
